AI can be transformative for all areas of healthcare, but often these systems are built off biased datasets that don’t reflect the true diversity of the general public – leading to approaches that only work for specific populations. It might…
Pharmaceutical brands had their sales staff grounded during the COVID-19 pandemic. As a result, marketers within those organizations – which had primarily focused on in-person communications to reach physicians – were forced to swiftly shift to a digital approach. During…
Frustrated doctors want more empathy and relevant content from pharma on digital channels, a new Indegene study finds. Doctors’ digital dissatisfaction with pharma companies has jumped during the pandemic. Across media channels, dissatisfaction rates ranged from 23% to almost 50%…
“Keith, Kotler, Maslow” has long been the Holy Trinity of pharma marketing. Great ancient thinkers all aspiring marketers were taught to learn and respect, and to whom the smartest among us learnt to often refer to. This could be through…
The COVID-19 pandemic has irreversibly shifted the modern workplace. Many surveys have highlighted this shift, with changed expectations from both employers and employees following the departure from traditional workplaces. With employees also reporting improved work-life balance and increased productivity, coupled…
Ten months… In March 2020, the world was in the early stages of the COVID-19 pandemic. We shut entire countries down and grounded economies to a halt in an effort to slow the spread of the virus. Think back to…
Respondents considered their telehealth experiences to be positive, but less or just as preferable to in-person visits for most factors A new Health Union survey reveals that people with chronic conditions feel that telehealth, despite its convenience and increased use…
The industry went online as a result of COVID-19. But is this change here to stay? Are the days of queuing for coffee, rushing to symposiums, and the glitzy conference dinner a thing of the past? International reach Online learning…
While restrictions on travel could prevent coronavirus transmission in the short term, digital passports showing COVID-negative and vaccination status may help reopen airports and other badly hit areas of the economy. In the longer term, the government hopes that digital…
Expect to see a virtual component even when in-person medical meetings resume. If you didn’t fall in love with virtual medical meetings in 2020, let’s just say you’re not alone. They came with their fair share of downsides, including the…
The need for diversity in clinical trial populations has been a topic of discussion across regulators and the industry in general for decades. Despite the introduction of US policies, beginning with the 1993 National Institutes of Health (NIH) Revitalization Act…
A new Takeda study conducted by Ipsos MORI in the U.K. finds consumers and healthcare providers favour pharma companies with a clear sense of purpose. Thinking pharma might earn a reputation halo with its COVID-19 work? Not so fast, Takeda…
Bureaucracy, political upheaval, and lack of regulations continue to make Latin America a difficult market for European and North American pharma to enter – and COVID-19 has only worsened these issues. There are a number of companies that, even in…
Pharma Marketing: More community trust. Less forced connections. A recent UK survey found that only 14% percent of users mostly or completely trust lifestyle influencers, while 51% completely or mostly trust patient influencers. When it comes to branded pharma products,…
How securing supply in a time of crisis will ensure future access, build resilience, and transform relationships. Since the start of the year, pharmaceutical companies have been riding a rollercoaster of challenges as the various strands came together to threaten…
